Related Experiment Video
Updated: Jun 2, 2026
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Maximizing patient adherence for optimal outcomes in psoriasis
1Department of Dermatology, Whipps Cross University Hospital & Barts and London NHS Trust, London, UK. anthony.bewley@whippsx.nhs.uk
Summary
Psoriasis treatment adherence is poor due to various factors, including disease impact and medication issues. Improving patient-provider relationships and considering patient preferences can enhance adherence and outcomes.
Area of Science:
- Dermatology
- Patient Adherence Research
- Chronic Disease Management
Background:
- Psoriasis is a chronic, disabling skin condition with significant impact on quality of life.
- Poor adherence to long-term treatment regimens is a major challenge in managing psoriasis.
- Adherence issues encompass both failure to fill prescriptions (primary) and incorrect medication use (secondary).
Purpose of the Study:
- To highlight the problem of treatment adherence in psoriasis.
- To identify factors contributing to poor adherence.
- To discuss strategies for improving adherence and patient outcomes.
Main Methods:
- Review of factors influencing adherence to topical psoriasis treatments.
- Discussion based on a presentation at the 19th Congress of the European Academy of Dermatology and Venereology.
- Analysis of patient-reported issues, including self-image and stigmatization.
Main Results:
- Adherence is negatively affected by efficacy, ease of use, convenience, and the healthcare professional-patient relationship.
- Psychological distress and stigmatization associated with psoriasis significantly impact adherence.
- Patient preferences for treatment vehicles and a strong patient-provider relationship are key factors for improvement.
Conclusions:
- Addressing both physical and psychological aspects of psoriasis is crucial for effective management.
- Improving the healthcare professional-patient relationship and personalizing treatment can enhance adherence.
- Nurses play a vital role in patient education and long-term care to improve adherence, outcomes, and quality of life.
More Related Videos
Related Concept Videos
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:11Guidelines for Writing Outcome
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...